HOCXF yields 666.67% · PFE yields 6.13%● Live data
📍 HOCXF pulled ahead of the other in Year 1
Combined, HOCXF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of HOCXF + PFE for your $10,000?
Promotora de Hoteles Norte 19, S.A.B. de C.V. develops, operates, and manages hotels in Mexico, Costa Rica, Colombia, and Chile. The company operates hotels under the City Junior by Marriott, City Express Suites by Marriott, City Express by Marriott, City Express Plus by Marriott, and City Centro by Marriott brands. It also provides marketing, technical, and administrative; real estate development; restaurant operation and catering; and IT, server maintenance, update, and equipment rental services, as well as software platforms and applications; and dashboards for hotel managers and operating teams. In addition, the company develops Front2Go, a property management system; hires personnel or third parties for the development of civil works; and invests in hospitality industry projects. It serves business travelers. The company was formerly known as Hoteles City Express, S.A.B. de C.V. and changed its name to Promotora de Hoteles Norte 19, S.A.B. de C.V. in April 2024. Promotora de Hoteles Norte 19, S.A.B. de C.V. was incorporated in 2002 and is headquartered in Mexico City, Mexico.
Full HOCXF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.